| Reducing endogenous tau ameliorates amyloid ß-induced deficits in an Alzheimer's disease mouse model ED Roberson, K Scearce-Levie, JJ Palop, F Yan, IH Cheng, T Wu, ... Science 316 (5825), 750-754, 2007 | 2315 | 2007 |
| Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration D Zwilling, SY Huang, KV Sathyasaikumar, FM Notarangelo, P Guidetti, ... Cell 145 (6), 863-874, 2011 | 520 | 2011 |
| Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models IH Cheng, K Scearce-Levie, J Legleiter, JJ Palop, H Gerstein, N Bien-Ly, ... Journal of Biological Chemistry 282 (33), 23818-23828, 2007 | 501 | 2007 |
| Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice FM Harris, WJ Brecht, Q Xu, I Tesseur, L Kekonius, T Wyss-Coray, JD Fish, ... Proceedings of the National Academy of Sciences 100 (19), 10966-10971, 2003 | 433 | 2003 |
| Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor BA Rocha, K Scearce-Levie, JJ Lucas, N Hiroi, N Castanon, JC Crabbe, ... Nature 393 (6681), 175-178, 1998 | 415 | 1998 |
| Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations Z Sheng, S Zhang, D Bustos, T Kleinheinz, CE Le Pichon, SL Dominguez, ... Science translational medicine 4 (164), 164ra161-164ra161, 2012 | 396 | 2012 |
| Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease RO Sanchez-Mejia, JW Newman, S Toh, GQ Yu, Y Zhou, B Halabisky, ... Nature neuroscience 11 (11), 1311-1318, 2008 | 385 | 2008 |
| Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease J Chin, JJ Palop, J Puoliväli, C Massaro, N Bien-Ly, H Gerstein, ... Journal of Neuroscience 25 (42), 9694-9703, 2005 | 367 | 2005 |
| Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates YJ Yu, JK Atwal, Y Zhang, RK Tong, KR Wildsmith, C Tan, N Bien-Ly, ... Science translational medicine 6 (261), 261ra154-261ra154, 2014 | 365 | 2014 |
| A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo JK Atwal, Y Chen, C Chiu, DL Mortensen, WJ Meilandt, Y Liu, CE Heise, ... Science translational medicine 3 (84), 84ra43-84ra43, 2011 | 299 | 2011 |
| Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein … L Esposito, J Raber, L Kekonius, F Yan, GQ Yu, N Bien-Ly, J Puoliväli, ... Journal of Neuroscience 26 (19), 5167-5179, 2006 | 279 | 2006 |
| Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier JA Couch, YJ Yu, Y Zhang, JM Tarrant, RN Fuji, WJ Meilandt, H Solanoy, ... Science translational medicine 5 (183), 183ra57-183ra57, 2013 | 259 | 2013 |
| Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Aβ oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice WJ Meilandt, M Cisse, K Ho, T Wu, LA Esposito, K Scearce-Levie, ... Journal of Neuroscience 29 (7), 1977-1986, 2009 | 186 | 2009 |
| Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice JJ Lucas, A Yamamoto, K Scearce-Levie, F Saudou, R Hen Journal of Neuroscience 18 (14), 5537-5544, 1998 | 177 | 1998 |
| Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors AA Estrada, X Liu, C Baker-Glenn, A Beresford, DJ Burdick, M Chambers, ... Journal of medicinal chemistry 55 (22), 9416-9433, 2012 | 156 | 2012 |
| Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease CE Le Pichon, WJ Meilandt, S Dominguez, H Solanoy, H Lin, H Ngu, ... Science translational medicine 9 (403), eaag0394, 2017 | 132 | 2017 |
| Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors AA Estrada, BK Chan, C Baker-Glenn, A Beresford, DJ Burdick, ... Journal of medicinal chemistry 57 (3), 921-936, 2014 | 132 | 2014 |
| Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies DW Shineman, GS Basi, JL Bizon, CA Colton, BD Greenberg, BA Hollister, ... Alzheimer's research & therapy 3, 1-13, 2011 | 132 | 2011 |
| Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice SC Dulawa, R Hen, K Scearce-Levie, MA Geyer Psychopharmacology 132, 125-134, 1997 | 132 | 1997 |
| Antibody-mediated targeting of tau in vivo does not require effector function and microglial engagement SH Lee, CE Le Pichon, O Adolfsson, V Gafner, M Pihlgren, H Lin, ... Cell reports 16 (6), 1690-1700, 2016 | 118 | 2016 |
